Our present results revealed that activation of GPR30 can significantly inhibit ER− breast cancer cell proliferation by G2/M-phase arrest and mitochondrial-related apoptosis via multiple intracellular signaling pathways as summarized in Figure 8. The gene discussed is GPER1; the disease is breast carcinoma.